ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Ambrx, BeiGene to develop next-generation biologics biospectrumasia
March 08, 2019Ambrx to receive an upfront payment of $10 million to apply its proprietary Expanded Genetic Code platforms to discover novel biologic drug candidates in this collaboration with BeiGene
Pharma Sources Insight January 2025
